Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers

NCT03495609 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

hCG
BRCA1 Mutation
BRCA2 Mutation

Interventions

DRUG: Ovitrelle

Sponsor

University Hospital, Ghent

Collaborators

[object Object]
[object Object]